BioLineRx Ltd. Weighted Average Remaining Contractual Life Of Outstanding Share Options
BioLineRx Ltd. (BLRX) had Weighted Average Remaining Contractual Life Of Outstanding Share Options of 7.5 Y as of 2018-12-31, per its 20-F filed 2019-03-28.
Discontinued › Notes
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions · last filed 2019-03-28
- 2018-12-31: Weighted Average Remaining Contractual Life Of Outstanding Share Options 7.50 Y.
- 2017-12-31: Weighted Average Remaining Contractual Life Of Outstanding Share Options 7.80 Y.
- 2016-12-31: Weighted Average Remaining Contractual Life Of Outstanding Share Options 5.50 Y.
- 2015-12-31: Weighted Average Remaining Contractual Life Of Outstanding Share Options 5.00 Y.
| Period end | Weighted Average Remaining Contractual Life Of Outstanding Share Options |
|---|---|
| 2018-12-31 | 7.50 Y 20-F · filed 2019-03-28 |
| 2017-12-31 | 7.80 Y 20-F · filed 2019-03-28 |
| 2016-12-31 | 5.50 Y 20-F · filed 2019-03-28 |
| 2015-12-31 | 5.00 Y 20-F · filed 2018-03-06 |